Both in Biotechnology
Fate Therapeutics vs Lexeo Therapeutics
Over the past year FATE returned +64.3% and LXEO returned −64.0%; their daily moves had a correlation of 0.27.
FATE +64.3% LXEO −64.0%Growth of $1, one year, split-adjusted
| Metric | FATE | LXEO |
|---|---|---|
| Price | $2.07 | $3.26 |
| Market cap | $248.0M | $267.2M |
| Today | +1.47% | +4.66% |
| 1 month | −9.6% | −1.4% |
| 6 months | −9.6% | −47.8% |
| Year to date | +110.7% | −67.2% |
| 1 year | +64.3% | −64.0% |
| Revenue growth (YoY) | +9.2% | — |
| Gross margin | 100.0% | — |
| Net margin | −1448.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 38.2× | — |
| Net cash | $153.8M | $211.1M |
| Dividend yield | — | — |
| Volatility (60d) | 56.3% | 69.5% |
| Short % of float | 10.4% | 22.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).